Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries

Background: The World Health Organization (WHO) recommends a 2-dose HPV vaccine schedule for girls aged 9–14 years. As randomised controlled trials assessing the immunogenicity and efficacy of a 1-dose schedule are ongoing, we interviewed immunisation programme managers and advisors in low and middl...

Full description

Bibliographic Details
Main Authors: Katherine E. Gallagher, Helen Kelly, Naomi Cocks, Sandra Dixon, Sandra Mounier-Jack, Natasha Howard, Deborah Watson-Jones
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Papillomavirus Research
Online Access:http://www.sciencedirect.com/science/article/pii/S2405852118300934